During the past decade, Northeast Urogynecology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeast Urogynecology" #1 collaborator was "Regulatory and Clinical Research Institute (RCRI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Northeast Urogynecology" are "Stress Urinary Incontinence" (1 trials), "Urinary Bladder, Overactive" (1 trials) and "Urinary Incontinence, Stress" (1 trials). Many other conditions were trialed in "Northeast Urogynecology" in a lesser frequency.

Most popular intervention types in "Northeast Urogynecology" are "Device" (2 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AttenueX IntraVesical System" (1 trials), "Bulkamid" (1 trials), "Contigen" (1 trials), "Fesoterodine 8 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northeast Urogynecology" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Northeast Urogynecology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Northeast Urogynecology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northeast Urogynecology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".